April 2012 FDA Recall Propofol by Hospira, Inc.
D-1382-2012 - Presence of Particulate Matter

This Class II drug recall was voluntarily initiated by Hospira, Inc. on April 11, 2012 for the product Propofol. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1382-2012

Reason for Recall
Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel
Initiated
04-11-2012
Reported
06-20-2012
Quantity
a) 36,125 vials; b) 31,280 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Propofol Injectable Emulsion, 1%, (10mg/mL), packaged in a) 200 mg/20 mL, 5 Units x 20 mL Single patient infusion vials per carton (NDC 0409-4699-30); b) 1 g/100 mL, 10 Units x 100 mL Single patient infusion vials per carton (NDC 0409-4699-24); Rx only, Hospira, Inc., Lake Forest, IL 60045, USA.

Batch or Lot Expiration Information

Lot# : a) 03440DJ*, Exp 1MAR2013; b) 07947DJ, Exp 1JUL2013; 10134DJ, Exp 1OCT2013; Note: * the lot may be followed by 01.